Diebold Nixdorf, Incorporated
DBD
$79.63
-$1.62-1.99%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.66% | 1.95% | -2.61% | -6.06% | -4.62% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.66% | 1.95% | -2.61% | -6.06% | -4.62% |
| Cost of Revenue | 6.91% | 1.75% | -3.33% | -6.26% | -7.33% |
| Gross Profit | 26.78% | 2.52% | -0.53% | -5.50% | 5.16% |
| SG&A Expenses | -5.33% | 2.84% | 4.23% | 0.07% | 22.77% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -166.67% | -93.33% | 105.56% | -70.00% | -88.46% |
| Total Operating Expenses | 4.46% | 1.42% | -1.83% | -5.20% | -3.34% |
| Operating Income | 135.79% | 7.60% | -10.82% | -18.02% | -22.35% |
| Income Before Tax | 424.37% | 525.61% | -62.61% | 43.27% | -44.39% |
| Income Tax Expenses | 116.36% | -67.89% | -85.00% | 29.03% | 466.67% |
| Earnings from Continuing Operations | 689.06% | 292.17% | -14.19% | 46.43% | -72.05% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -12.50% | 14.29% | -600.00% | -33.33% | -33.33% |
| Net Income | 785.71% | 283.48% | -18.12% | 43.15% | -74.89% |
| EBIT | 135.79% | 7.60% | -10.82% | -18.02% | -22.35% |
| EBITDA | 65.58% | 6.49% | -7.00% | -10.98% | -19.98% |
| EPS Basic | 830.49% | 289.02% | -17.23% | 43.16% | -74.89% |
| Normalized Basic EPS | 263.65% | 58.21% | -42.06% | -51.61% | -30.88% |
| EPS Diluted | 815.58% | 285.00% | -17.23% | 43.16% | -74.89% |
| Normalized Diluted EPS | 258.66% | 56.08% | -42.36% | -51.61% | -30.88% |
| Average Basic Shares Outstanding | -4.79% | -2.93% | -1.06% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | -3.46% | -1.60% | -0.53% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |